Prellis, Bristol Myers Squibb collaborate to discover antibodies
Prellis Biologics and Bristol Myers Squibb have signed a multi-target collaboration and license agreement to discover antibodies.
Stay updated with breaking news from Prellis Biologic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Prellis Biologics and Bristol Myers Squibb have signed a multi-target collaboration and license agreement to discover antibodies.
San Francisco, CA (PRWEB) December 15, 2021 -- Prellis Biologics announced today that it has closed a $14.5 million Series B financing round, led by Celesta